ESR1 and breast carcinoma: In line with our findings, previous report showed that gas chromatography-time of flight-mass spectrometry (GC-TOF–MS) based comparative metabolomic analysis of breast cancer tissues showed a significant difference in the central metabolism between estrogen receptor positive and estrogen receptor negative tissues26.